Literature DB >> 24091888

Dynamics of pneumococcal transmission in vaccine-naive children and their HIV-infected or HIV-uninfected mothers during the first 2 years of life.

Tinevimbo Shiri, Kari Auranen, Marta C Nunes, Peter V Adrian, Nadia van Niekerk, Linda de Gouveia, Anne von Gottberg, Keith P Klugman, Shabir A Madhi.   

Abstract

Pneumococcal vaccine-naïve mother-child dyads in South Africa had nasopharyngeal swabs taken 9 times within the first 2 years of the children's lives between January 2007 and May 2009. To quantify the strength of the association of serotype-specific carriage in mother-child dyads, a stochastic transmission model was fitted to the data. Children were more susceptible to individual serotypes included in the 7-valent pneumococcal conjugate vaccine (PCV7) transmitted by their mothers than vice versa; however, children infected their mothers with these serotypes more frequently than mothers infected children. The child-to-mother steady-state forces of pneumococcal acquisition were between 0.36 and 3.29 (per 1,000 days) compared with 0.06-0.51 for mother-to-child transmission. Although children of mothers infected with human immunodeficiency virus were more often exposed to PCV7 serotypes by their mothers, their risk of acquisition remained low compared with the risk of child-to-mother transmission. Mothers acquired pneumococci at lower rates (per 1,000 days) from unmeasured exposure within families and in the wider community (range, 0.12-1.69 per 1,000 days) than did children (range, 1.10-5.21 per 1,000 days). Pneumococcal immunization of young children is expected to have an indirect effect of reducing PCV7 serotype maternal colonization and possibly disease even in settings such as ours, in which there is a high prevalence of human immunodeficiency virus-infected mothers.

Entities:  

Keywords:  HIV; Streptococcus pneumoniae; colonization; force of infection; mother-child pairs; pneumococcal conjugate vaccine; pneumococcal exposure; stochastic model

Mesh:

Substances:

Year:  2013        PMID: 24091888     DOI: 10.1093/aje/kwt200

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  12 in total

1.  Management of diarrhea in HIV-affected infants and children.

Authors:  Patricia B Pavlinac; Kirkby D Tickell; Judd L Walson
Journal:  Expert Rev Anti Infect Ther       Date:  2014-11-11       Impact factor: 5.091

2.  Pneumococcal within-host diversity during colonization, transmission and treatment.

Authors:  Gerry Tonkin-Hill; Clare Ling; Chrispin Chaguza; Susannah J Salter; Pattaraporn Hinfonthong; Elissavet Nikolaou; Natalie Tate; Andrzej Pastusiak; Claudia Turner; Claire Chewapreecha; Simon D W Frost; Jukka Corander; Nicholas J Croucher; Paul Turner; Stephen D Bentley
Journal:  Nat Microbiol       Date:  2022-10-10       Impact factor: 30.964

3.  Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae strains carried by children infected with human immunodeficiency virus.

Authors:  Dodi Safari; Nia Kurniati; Lia Waslia; Miftahuddin Majid Khoeri; Tiara Putri; Debby Bogaert; Krzysztof Trzciński
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

4.  Pneumococcal Acquisition Among Infants Exposed to HIV in Rural Malawi: A Longitudinal Household Study.

Authors:  Ellen Heinsbroek; Terence Tafatatha; Christina Chisambo; Amos Phiri; Oddie Mwiba; Bagrey Ngwira; Amelia C Crampin; Jonathan M Read; Neil French
Journal:  Am J Epidemiol       Date:  2015-12-01       Impact factor: 4.897

5.  Identifying transmission routes of Streptococcus pneumoniae and sources of acquisitions in high transmission communities.

Authors:  B M Althouse; L L Hammitt; L Grant; B G Wagner; R Reid; F Larzelere-Hinton; R Weatherholtz; K P Klugman; G L Rodgers; K L O'Brien; H Hu
Journal:  Epidemiol Infect       Date:  2017-08-29       Impact factor: 2.451

6.  Community-Acquired Pneumonia in HIV-Infected Individuals.

Authors:  James Brown; Marc Lipman
Journal:  Curr Infect Dis Rep       Date:  2014-03       Impact factor: 3.725

7.  Reply to "no clinical association of live attenuated influenza vaccine with nasal carriage of bacteria or acute otitis media": specific recommendations for future studies.

Authors:  Michael J Mina; Keith P Klugman
Journal:  mBio       Date:  2014-05-13       Impact factor: 7.867

8.  Long-term effects of penicillin resistance and fitness cost on pneumococcal transmission dynamics in a developed setting.

Authors:  Diana Tilevik
Journal:  Infect Ecol Epidemiol       Date:  2016-05-19

9.  Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial.

Authors:  Shabir A Madhi; Eleonora Aml Mutsaerts; Alane Izu; Welekazi Boyce; Sutika Bhikha; Benit T Ikulinda; Lisa Jose; Anthonet Koen; Amit J Nana; Andrew Moultrie; Lucy Roalfe; Adam Hunt; David Goldblatt; Clare L Cutland; Jeffrey R Dorfman
Journal:  Lancet Infect Dis       Date:  2020-08-25       Impact factor: 25.071

10.  Estimating the contribution of different age strata to vaccine serotype pneumococcal transmission in the pre vaccine era: a modelling study.

Authors:  Stefan Flasche; Marc Lipsitch; John Ojal; Amy Pinsent
Journal:  BMC Med       Date:  2020-06-10       Impact factor: 11.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.